Literature DB >> 8508745

Effect of stabling on bronchoalveolar cells obtained from normal and COPD horses.

G M Tremblay1, C Ferland, J M Lapointe, A Vrins, J P Lavoie, Y Cormier.   

Abstract

Bronchoalveolar lavages (BAL) were performed before and after 3 weeks of housing in 5 horses suffering from COPD and 5 normal horses. In the two groups, the total number of cells recovered remained unchanged after stabling. The most common cell populations in BAL fluid of control animals were alveolar macrophages (46.4%) and lymphocytes (44.9%). The percentage of neutrophils increased after stabling from 8.7% to 27.6%. In COPD horses, lymphocytes predominated (40.7%) in animals at pasture with neutrophils increasing from 29.4% to 71.6% after stabling. After fractionation by Percoll density gradient, alveolar macrophages and neutrophils from normal and COPD horses had a similar density distribution. After stabling, these cells from normal horses were increased in the low density layers, while those from COPD horses were predominantly in the hyperdense layers. Therefore, BAL cells obtained from COPD animals at pasture and after stabling differ from those of control horses in the same environment, not only in their populations but also in their buoyant densities. These differences could be related to different states of cellular activation and perhaps be responsible for disease activity in the COPD horses.

Entities:  

Mesh:

Year:  1993        PMID: 8508745     DOI: 10.1111/j.2042-3306.1993.tb02941.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  9 in total

1.  Association between respiratory disease and bacterial and viral infections in British racehorses.

Authors:  J L N Wood; J R Newton; N Chanter; J A Mumford
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 2.  Investigating the link between particulate exposure and airway inflammation in the horse.

Authors:  K M Ivester; L L Couëtil; N J Zimmerman
Journal:  J Vet Intern Med       Date:  2014-10-01       Impact factor: 3.333

3.  Tracheobronchoscopic Assessment of Exercise-Induced Pulmonary Hemorrhage and Airway Inflammation in Barrel Racing Horses.

Authors:  R Léguillette; M Steinmann; S L Bond; B Stanton
Journal:  J Vet Intern Med       Date:  2016-06-08       Impact factor: 3.333

Review 4.  Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?

Authors:  Ann Kristin Barton; Heidrun Gehlen
Journal:  Mediators Inflamm       Date:  2016-12-07       Impact factor: 4.711

5.  Immunohistochemical Expression of Neurokinin-A and Interleukin-8 in the Bronchial Epithelium of Horses with Severe Equine Asthma Syndrome during Asymptomatic, Exacerbation, and Remission Phase.

Authors:  Maria Morini; Angelo Peli; Riccardo Rinnovati; Giuseppe Magazzù; Noemi Romagnoli; Alessandro Spadari; Marco Pietra
Journal:  Animals (Basel)       Date:  2021-05-12       Impact factor: 2.752

6.  Environmental exposures and airway inflammation in young thoroughbred horses.

Authors:  K M Ivester; L L Couëtil; G E Moore; N J Zimmerman; R E Raskin
Journal:  J Vet Intern Med       Date:  2014-03-12       Impact factor: 3.333

7.  Development of a Semiquantitative Histological Score for the Diagnosis of Heaves Using Endobronchial Biopsy Specimens in Horses.

Authors:  M Bullone; P Hélie; P Joubert; J-P Lavoie
Journal:  J Vet Intern Med       Date:  2016-08-16       Impact factor: 3.333

8.  An observational study of environmental exposures, airway cytology, and performance in racing thoroughbreds.

Authors:  Kathleen M Ivester; Laurent L Couëtil; George E Moore
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

9.  Effects of nebulized dexamethasone on the respiratory microbiota and mycobiota and relative equine herpesvirus-1, 2, 4, 5 in an equine model of asthma.

Authors:  Stephanie L Bond; Matthew Workentine; Jana Hundt; James R Gilkerson; Renaud Léguillette
Journal:  J Vet Intern Med       Date:  2019-12-03       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.